covaxin
-
No proof of Covaxin’s efficacy against Omicron strain in Bharat Biotech’s study on booster dose
Scroll Staff
-
Fact check: No, WHO has not granted Covaxin emergency use nod for children
Isha Bajpai, Factchecker.in
-
India begins vaccinating children aged 15 to 18 years against Covid
Scroll Staff
-
Mumbai: Co-Win glitches mar children’s Covid vaccine registration, says report
Scroll Staff
-
Covaxin has shown good immune response among children, says Covid panel chief
Scroll Staff
-
Top 10 Omicron updates: Delhi imposes night curfew between 11 pm and 5 am from Monday
Scroll Staff
-
Covaxin receives DCGI approval for use in children from 12 to 18 years
Scroll Staff
-
Covid: 96% of vaccine jabs administered since May 1 were at government centres, says health ministry
Scroll Staff
-
Covaxin shows 50% efficacy against symptomatic cases of coronavirus: Lancet study
Scroll Staff
-
Coronavirus: India reports 7,579 new cases – lowest in 543 days
Scroll Staff
-
Covaxin is 77.8% effective in symptomatic cases, shows phase 3 trial data: Lancet study
Scroll Staff
-
Covid: UK to recognise Covaxin as an approved vaccine from November 22
Scroll Staff
-
Coronavirus: Bharat Biotech’s US partner seeks emergency approval to Covaxin for children
Scroll Staff
-
Covaxin for children is likely to be approved faster, says WHO chief scientist
Scroll Staff
-
Coronavirus: Travellers who have taken Covaxin shot can enter United States from November 8
Scroll Staff
-
Coronavirus: India logs 12,885 new cases, Centre flags rise in infections in Andhra, Himachal, J&K
Scroll Staff
-
The big news: Centre cuts excise duty to reduce fuel prices, and nine other top stories
Scroll Staff
-
Coronavirus: Covaxin approved for emergency use by WHO
Scroll Staff
-
Covid: Australia recognises Covaxin for travel as it eases border restrictions
Scroll Staff
-
Covid-19: WHO trusts Indian vaccine industry, says official on delay in granting approval to Covaxin
Scroll Staff